FDA Inspection 1053657 — MedaPhase, Inc
The FDA completed an inspection of MedaPhase, Inc on May 14, 2018 in Newnan, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 14, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newnan, GA (United States)
Additional Details
Clinical BA/BE